| Dr Robert Anthony Guardiano, DO | |
|
51 Railroad St, 2nd Floor, Keene, NH 03431-3987 | |
| (603) 354-5454 | |
| Not Available |
| Full Name | Dr Robert Anthony Guardiano |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 26 Years |
| Location | 51 Railroad St, Keene, New Hampshire |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568435386 | NPI | - | NPPES |
| 30226765 | Medicaid | NH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 0102831108 (Virginia) | Secondary |
| 207N00000X | Dermatology | 13860 (New Hampshire) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Cheshire Medical Center | Keene, NH | Hospital |
| Mary Hitchcock Memorial Hospital | Lebanon, NH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cheshire Medical Center | 1456260165 | 155 |
News Archive
In March 2010, the Democrat-controlled Congress forced the passage of the Patient Protection and Affordable Care Act (now known as ObamaCare) over the strong objections of the majority of Americans, most of whom were either already receiving taxpayer-funded health insurance or were satisfied with their private coverage.
Ameritox, the leader in pain-medication monitoring, today announced the launch of Rx Guardian CD, its next-generation pain-medication monitoring solution and part of the patented Rx Guardian process.
Taiho Pharmaceutical Co., Ltd., and its parent company, Otsuka Holdings Co., Ltd., announced today that the Committee for Medicinal Products for Human Use (CHMP), a division of the European Medicines Agency (EMA), has issued an opinion recommending approval of Teysuno™ (S-1), a novel oral anti-cancer agent, intended for the treatment of advanced gastric cancer in adults when given in combination with cisplatin.
Researchers from Brown University have shown how tiny graphene microsheets - ultra-thin materials with a number of commercial applications - could be big trouble for human cells.
› Verified 3 days ago
| Entity Name | Dartmouth-hitchcock Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386697803 PECOS PAC ID: 4183537509 Enrollment ID: O20031111000313 |
News Archive
In March 2010, the Democrat-controlled Congress forced the passage of the Patient Protection and Affordable Care Act (now known as ObamaCare) over the strong objections of the majority of Americans, most of whom were either already receiving taxpayer-funded health insurance or were satisfied with their private coverage.
Ameritox, the leader in pain-medication monitoring, today announced the launch of Rx Guardian CD, its next-generation pain-medication monitoring solution and part of the patented Rx Guardian process.
Taiho Pharmaceutical Co., Ltd., and its parent company, Otsuka Holdings Co., Ltd., announced today that the Committee for Medicinal Products for Human Use (CHMP), a division of the European Medicines Agency (EMA), has issued an opinion recommending approval of Teysuno™ (S-1), a novel oral anti-cancer agent, intended for the treatment of advanced gastric cancer in adults when given in combination with cisplatin.
Researchers from Brown University have shown how tiny graphene microsheets - ultra-thin materials with a number of commercial applications - could be big trouble for human cells.
› Verified 3 days ago
| Entity Name | Mary Hitchcock Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023092053 PECOS PAC ID: 4486561164 Enrollment ID: O20031126000258 |
News Archive
In March 2010, the Democrat-controlled Congress forced the passage of the Patient Protection and Affordable Care Act (now known as ObamaCare) over the strong objections of the majority of Americans, most of whom were either already receiving taxpayer-funded health insurance or were satisfied with their private coverage.
Ameritox, the leader in pain-medication monitoring, today announced the launch of Rx Guardian CD, its next-generation pain-medication monitoring solution and part of the patented Rx Guardian process.
Taiho Pharmaceutical Co., Ltd., and its parent company, Otsuka Holdings Co., Ltd., announced today that the Committee for Medicinal Products for Human Use (CHMP), a division of the European Medicines Agency (EMA), has issued an opinion recommending approval of Teysuno™ (S-1), a novel oral anti-cancer agent, intended for the treatment of advanced gastric cancer in adults when given in combination with cisplatin.
Researchers from Brown University have shown how tiny graphene microsheets - ultra-thin materials with a number of commercial applications - could be big trouble for human cells.
› Verified 3 days ago
| Entity Name | Dartmouth-hitchcock Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548210198 PECOS PAC ID: 4183537509 Enrollment ID: O20040809000442 |
News Archive
In March 2010, the Democrat-controlled Congress forced the passage of the Patient Protection and Affordable Care Act (now known as ObamaCare) over the strong objections of the majority of Americans, most of whom were either already receiving taxpayer-funded health insurance or were satisfied with their private coverage.
Ameritox, the leader in pain-medication monitoring, today announced the launch of Rx Guardian CD, its next-generation pain-medication monitoring solution and part of the patented Rx Guardian process.
Taiho Pharmaceutical Co., Ltd., and its parent company, Otsuka Holdings Co., Ltd., announced today that the Committee for Medicinal Products for Human Use (CHMP), a division of the European Medicines Agency (EMA), has issued an opinion recommending approval of Teysuno™ (S-1), a novel oral anti-cancer agent, intended for the treatment of advanced gastric cancer in adults when given in combination with cisplatin.
Researchers from Brown University have shown how tiny graphene microsheets - ultra-thin materials with a number of commercial applications - could be big trouble for human cells.
› Verified 3 days ago
| Entity Name | Cheshire Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093803397 PECOS PAC ID: 1456260165 Enrollment ID: O20070913000090 |
News Archive
In March 2010, the Democrat-controlled Congress forced the passage of the Patient Protection and Affordable Care Act (now known as ObamaCare) over the strong objections of the majority of Americans, most of whom were either already receiving taxpayer-funded health insurance or were satisfied with their private coverage.
Ameritox, the leader in pain-medication monitoring, today announced the launch of Rx Guardian CD, its next-generation pain-medication monitoring solution and part of the patented Rx Guardian process.
Taiho Pharmaceutical Co., Ltd., and its parent company, Otsuka Holdings Co., Ltd., announced today that the Committee for Medicinal Products for Human Use (CHMP), a division of the European Medicines Agency (EMA), has issued an opinion recommending approval of Teysuno™ (S-1), a novel oral anti-cancer agent, intended for the treatment of advanced gastric cancer in adults when given in combination with cisplatin.
Researchers from Brown University have shown how tiny graphene microsheets - ultra-thin materials with a number of commercial applications - could be big trouble for human cells.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Robert Anthony Guardiano, DO 51 Railroad St, 2nd Floor, Keene, NH 03431-3987 Ph: (603) 354-5454 | Dr Robert Anthony Guardiano, DO 51 Railroad St, 2nd Floor, Keene, NH 03431-3987 Ph: (603) 354-5454 |
News Archive
In March 2010, the Democrat-controlled Congress forced the passage of the Patient Protection and Affordable Care Act (now known as ObamaCare) over the strong objections of the majority of Americans, most of whom were either already receiving taxpayer-funded health insurance or were satisfied with their private coverage.
Ameritox, the leader in pain-medication monitoring, today announced the launch of Rx Guardian CD, its next-generation pain-medication monitoring solution and part of the patented Rx Guardian process.
Taiho Pharmaceutical Co., Ltd., and its parent company, Otsuka Holdings Co., Ltd., announced today that the Committee for Medicinal Products for Human Use (CHMP), a division of the European Medicines Agency (EMA), has issued an opinion recommending approval of Teysuno™ (S-1), a novel oral anti-cancer agent, intended for the treatment of advanced gastric cancer in adults when given in combination with cisplatin.
Researchers from Brown University have shown how tiny graphene microsheets - ultra-thin materials with a number of commercial applications - could be big trouble for human cells.
› Verified 3 days ago
Ashley Rae Group, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 312 Marlboro St, Keene, NH 03431 Phone: 603-354-6570 | |
Dr. David Fleming Horne, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 312 Marlboro St, Keene, NH 03431 Phone: 603-354-6570 | |
Mahin Alamgir, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 51 Railroad St, Keene, NH 03431 Phone: 603-354-6571 | |
Dr. Gregory Paul Seymour, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 590 Court St, Keene, NH 03431 Phone: 603-354-5454 |